|
|
|
Volumn 9 Suppl 3, Issue , 2009, Pages
|
|
Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DEFERIPRONE;
FERRITIN;
IMMUNOSUPPRESSIVE AGENT;
IRON CHELATING AGENT;
PYRIDONE DERIVATIVE;
BETA THALASSEMIA;
BLOOD;
CYTOLOGY;
DISEASE COURSE;
DNA METHYLATION;
ERYTHROCYTE;
ERYTHROCYTE TRANSFUSION;
HUMAN;
IRON OVERLOAD;
METHODOLOGY;
METHYLATION;
MYELODYSPLASTIC SYNDROME;
REVIEW;
RISK;
TREATMENT OUTCOME;
BETA-THALASSEMIA;
DISEASE PROGRESSION;
DNA METHYLATION;
ERYTHROCYTE TRANSFUSION;
ERYTHROCYTES;
FERRITINS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
IRON CHELATING AGENTS;
IRON OVERLOAD;
METHYLATION;
MYELODYSPLASTIC SYNDROMES;
PYRIDONES;
RISK;
TREATMENT OUTCOME;
|
|
EID: 74049137554
PISSN: None
EISSN: 19380712
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (16)
|
|
References (60)
|
